SlideShare a Scribd company logo
Historical Milestones in
Hypertension and its Management
Dr. Nagula Praveen
MD,DM
Associate Professor of Cardiology
Osmania General Hospital
Hyderabad
Study the past, if you would define the future.
- Confucius
WILLIAM HARVEY
English Physician
Circulation of the Heart
and Blood
1628
STEPHEN HALES
English Clergyman
First person to
measure blood pressure
1733
RIVA ROCCI
Italian
Mercury sphygmomanometer
1896
N.C. KOROTKOFF
Russian
1905
reported on the
method of
auscultation of
brachial artery, the
method which is
widely used today.
The term essential hypertension ('Essentielle Hypertonie')
was coined by Eberhard Frank in 1911 to describe
elevated blood pressure for which no cause could be found.
Thomas Young -
Hypertension as a disease 1808
Malignant hypertension, a term used to describe severe
hypertension which eventually resulted in death, was first
used by The Mayo Clinic in 1928.
“Hypertension may be an important compensatory
mechanism which should not be tampered with, even were it
certain that we could control it”.
–Paul Dudley White, Father of Preventive Cardiology.
FRANKLIN D. ROOSEVELT
The 32nd President of the United States
President Franklin D. Roosevelt was given a clean bill
of health by his physician even when his BP was
recorded as ~220/120.
A few years later while at Yalta, Winston Churchill’s
personal physician noted in his diary that President
Roosevelt “appeared to be have had signs of
‘hardening of the arteries disease’ and had a few
months to live.”
President Roosevelt ultimately had a fatal
hemorrhagic stroke 2 months later, and his death
brought hypertension’s potential as a deadly to the
limelight.
Three years after Roosevelt’s death, the pivotal
National Heart Act was signed into law by President
Truman. The Act created the path for the study of
heart diseases and resulted in several studies
including the Framingham Heart Study.
Timeline of Hypertension History
Schematic model of the evolution of understanding and
approaches to hypertension in the 20th century.
First sphygmograph
Miguel Ondetti and David
Cushman, 1975 developed
Captopril, the first of a new class of
drugs known as angiotensin
converting enzyme (ACE) inhibitors.
James Whyte Black, 1962
Developed propranolol, a beta blocker
used for the treatment of heart disease
I wish I had my betablockers handy
-Dr. James Black, 1988
Evolution of Blood Pressure Clinical Practice
Guidelines
Conclusion:
This study showed the clinical efficacy, safety and acceptability of the
perindopril/indapamide/amlodipine SPC in patients with grade 2/3 hypertension inadequately
controlled with two drug therapy. The clinical effectiveness was observed in more than 96%
patients. The benefit of SPC therapy in hypertension control was reconfirmed in this study.
Hypertension Screening on Occasion
of World Hypertension Day 2022
• Of the approximately 4500 patients screened, around 800+
patients were screened at OGH, Hyderabad.
3565
922
Males Females
21
846
1723 1918
0
500
1000
1500
2000
2500
Hypertension
Normal
Pre
Hypertension
Hypertension
42.74%
38.39%
17.45%
Prehypertension is defined as a systolic pressure from 120-139 mmHg
and diastolic 80-89 mmHg
22
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
BMI
≥24.0 kg/m2 (Over weight/Obesity)
> = 24.0(over
weight/Obesity)
70.8 %
23
0
200
400
600
800
1000
1200
1400
1600
1800
2000
Diabetes
33 % are Diabetics
HISTORICAL ASPECTS OF HYPERTENSION

More Related Content

What's hot

Ontarget
OntargetOntarget
Angina Management with Metabolic Agents
Angina Management with Metabolic AgentsAngina Management with Metabolic Agents
Angina Management with Metabolic Agents
PERKI Pekanbaru
 
Diabetes mellitus and hypertension
Diabetes mellitus and hypertensionDiabetes mellitus and hypertension
Diabetes mellitus and hypertension
Nadia Shams
 
2018 ESC/ESH Guidelines for the management of arterial hypertension
2018 ESC/ESH Guidelines for the management of arterial hypertension2018 ESC/ESH Guidelines for the management of arterial hypertension
2018 ESC/ESH Guidelines for the management of arterial hypertension
Julfikar Saif
 
Aspirin for primary prevention of CVD
Aspirin for primary prevention of CVDAspirin for primary prevention of CVD
Aspirin for primary prevention of CVD
Pinkesh Parmar
 
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials  ...Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials  ...
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...
magdy elmasry
 
Management of Diabetes.pptx
Management of Diabetes.pptxManagement of Diabetes.pptx
Management of Diabetes.pptx
Oriba Dan Langoya
 
SGLT2 inhibitor trials
SGLT2 inhibitor trialsSGLT2 inhibitor trials
SGLT2 inhibitor trials
Dr. Rohan Sonawane
 
Empagliflozin glycemic control and beyond-Dr Shahjada Selim
Empagliflozin glycemic control and beyond-Dr Shahjada SelimEmpagliflozin glycemic control and beyond-Dr Shahjada Selim
Empagliflozin glycemic control and beyond-Dr Shahjada Selim
Bangabandhu Sheikh Mujib Medical University
 
Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...
Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...
Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...
InsideScientific
 
Historical perspective on the diagnosis of diabetes mellitus
Historical perspective on the diagnosis of diabetes mellitusHistorical perspective on the diagnosis of diabetes mellitus
Historical perspective on the diagnosis of diabetes mellitusAaron Neinstein
 
Ideal basal insulin: Degludeg
Ideal basal insulin: DegludegIdeal basal insulin: Degludeg
Ideal basal insulin: Degludeg
Bangabandhu Sheikh Mujib Medical University
 
Olmesartan induced enteropathy
Olmesartan induced enteropathyOlmesartan induced enteropathy
Olmesartan induced enteropathy
Naina Mohamed, PhD
 
ESC Guidelines for Heart Failure
ESC Guidelines for Heart FailureESC Guidelines for Heart Failure
ESC Guidelines for Heart Failure
Sociedad Española de Cardiología
 
W heart day 2018
W heart day 2018W heart day 2018
W heart day 2018
desktoppc
 
Hypertension in special situation
Hypertension in special situationHypertension in special situation
Hypertension in special situation
Rashna Sharmin
 
Metabolic Syndrome, Diabetes, and Cardiovascular Disease ... Metabolic Synd...
Metabolic Syndrome, Diabetes, and Cardiovascular Disease ... 	 Metabolic Synd...Metabolic Syndrome, Diabetes, and Cardiovascular Disease ... 	 Metabolic Synd...
Metabolic Syndrome, Diabetes, and Cardiovascular Disease ... Metabolic Synd...MedicineAndFamily
 
Telmisartan combination uses
Telmisartan combination usesTelmisartan combination uses
Telmisartan combination uses
BALASUBRAMANIAM IYER
 
RSSDI
RSSDI RSSDI
RSSDI
endodiabetes
 
Profile on olmesartan
Profile on olmesartanProfile on olmesartan
Profile on olmesartan
Govindanayagi P
 

What's hot (20)

Ontarget
OntargetOntarget
Ontarget
 
Angina Management with Metabolic Agents
Angina Management with Metabolic AgentsAngina Management with Metabolic Agents
Angina Management with Metabolic Agents
 
Diabetes mellitus and hypertension
Diabetes mellitus and hypertensionDiabetes mellitus and hypertension
Diabetes mellitus and hypertension
 
2018 ESC/ESH Guidelines for the management of arterial hypertension
2018 ESC/ESH Guidelines for the management of arterial hypertension2018 ESC/ESH Guidelines for the management of arterial hypertension
2018 ESC/ESH Guidelines for the management of arterial hypertension
 
Aspirin for primary prevention of CVD
Aspirin for primary prevention of CVDAspirin for primary prevention of CVD
Aspirin for primary prevention of CVD
 
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials  ...Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials  ...
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...
 
Management of Diabetes.pptx
Management of Diabetes.pptxManagement of Diabetes.pptx
Management of Diabetes.pptx
 
SGLT2 inhibitor trials
SGLT2 inhibitor trialsSGLT2 inhibitor trials
SGLT2 inhibitor trials
 
Empagliflozin glycemic control and beyond-Dr Shahjada Selim
Empagliflozin glycemic control and beyond-Dr Shahjada SelimEmpagliflozin glycemic control and beyond-Dr Shahjada Selim
Empagliflozin glycemic control and beyond-Dr Shahjada Selim
 
Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...
Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...
Cardiometabolic Disease Pathophysiology & Novel Therapies for Atherosclerosis...
 
Historical perspective on the diagnosis of diabetes mellitus
Historical perspective on the diagnosis of diabetes mellitusHistorical perspective on the diagnosis of diabetes mellitus
Historical perspective on the diagnosis of diabetes mellitus
 
Ideal basal insulin: Degludeg
Ideal basal insulin: DegludegIdeal basal insulin: Degludeg
Ideal basal insulin: Degludeg
 
Olmesartan induced enteropathy
Olmesartan induced enteropathyOlmesartan induced enteropathy
Olmesartan induced enteropathy
 
ESC Guidelines for Heart Failure
ESC Guidelines for Heart FailureESC Guidelines for Heart Failure
ESC Guidelines for Heart Failure
 
W heart day 2018
W heart day 2018W heart day 2018
W heart day 2018
 
Hypertension in special situation
Hypertension in special situationHypertension in special situation
Hypertension in special situation
 
Metabolic Syndrome, Diabetes, and Cardiovascular Disease ... Metabolic Synd...
Metabolic Syndrome, Diabetes, and Cardiovascular Disease ... 	 Metabolic Synd...Metabolic Syndrome, Diabetes, and Cardiovascular Disease ... 	 Metabolic Synd...
Metabolic Syndrome, Diabetes, and Cardiovascular Disease ... Metabolic Synd...
 
Telmisartan combination uses
Telmisartan combination usesTelmisartan combination uses
Telmisartan combination uses
 
RSSDI
RSSDI RSSDI
RSSDI
 
Profile on olmesartan
Profile on olmesartanProfile on olmesartan
Profile on olmesartan
 

Similar to HISTORICAL ASPECTS OF HYPERTENSION

Abc books cardiologia abc of-heart_failure
Abc books cardiologia   abc of-heart_failureAbc books cardiologia   abc of-heart_failure
Abc books cardiologia abc of-heart_failure
edubruno2015
 
Learning Objectives1. Describe why hypertension and diabet.docx
Learning Objectives1. Describe why hypertension and diabet.docxLearning Objectives1. Describe why hypertension and diabet.docx
Learning Objectives1. Describe why hypertension and diabet.docx
SHIVA101531
 
Treating angina
Treating anginaTreating angina
Treating angina
Ramachandra Barik
 
Historical developments; Trends n issues; Legal n ethical issues in d field o...
Historical developments; Trends n issues; Legal n ethical issues in d field o...Historical developments; Trends n issues; Legal n ethical issues in d field o...
Historical developments; Trends n issues; Legal n ethical issues in d field o...Ancy Das
 
Prof. J.P.Das Oration HEART FAILURE
Prof. J.P.Das Oration HEART FAILUREProf. J.P.Das Oration HEART FAILURE
Prof. J.P.Das Oration HEART FAILURE
drucsamal
 
Bloodless Medicine Caring Effectively For Patients Who Decline Blood Transf...
Bloodless Medicine   Caring Effectively For Patients Who Decline Blood Transf...Bloodless Medicine   Caring Effectively For Patients Who Decline Blood Transf...
Bloodless Medicine Caring Effectively For Patients Who Decline Blood Transf...mcolumbus
 
History of cardiology
History of cardiologyHistory of cardiology
History of cardiology
Dona Mathew
 
avanços diabetologia.pdf
avanços diabetologia.pdfavanços diabetologia.pdf
avanços diabetologia.pdf
MargareteApSantos
 
Beta blockers
Beta blockersBeta blockers
Beta blockers
Sayed Sileem
 
The history of paediatric cardiology
The history of paediatric cardiologyThe history of paediatric cardiology
The history of paediatric cardiology
Ramachandra Barik
 
Treatment of myocardial infarction,past& present
Treatment of myocardial infarction,past& presentTreatment of myocardial infarction,past& present
Treatment of myocardial infarction,past& present
Ameel Yaqo
 
CHRONOPHARMACOLOGY
CHRONOPHARMACOLOGYCHRONOPHARMACOLOGY
CHRONOPHARMACOLOGY
prajaktabhandarkar2
 
Heart disease reversal
Heart disease reversal Heart disease reversal
Heart disease reversal
John Bergman
 
History of blood transfusion.pptx
History of blood transfusion.pptxHistory of blood transfusion.pptx
History of blood transfusion.pptx
Umesh Prasad Gupta
 
Valvular Heart Disease A Century Of Progress
Valvular Heart Disease A Century Of ProgressValvular Heart Disease A Century Of Progress
Valvular Heart Disease A Century Of Progress
kops
 
HISTORY OF PARATHYROID SURGERY 2021.ppt
HISTORY OF PARATHYROID SURGERY 2021.pptHISTORY OF PARATHYROID SURGERY 2021.ppt
HISTORY OF PARATHYROID SURGERY 2021.ppt
Biblioteca Conrado F. Asenjo - RCM-UPR
 
Blood pressure and cholesterol
Blood pressure and cholesterolBlood pressure and cholesterol
Blood pressure and cholesterol
John Bergman
 
Anesthesiology
AnesthesiologyAnesthesiology
Anesthesiology
rahulverma1194
 
Soap analysis on Coronary Artery Disease: By RxVichuZ!
Soap analysis on Coronary Artery Disease: By RxVichuZ!Soap analysis on Coronary Artery Disease: By RxVichuZ!
Soap analysis on Coronary Artery Disease: By RxVichuZ!
RxVichuZ
 
ECG changes in anorexia nervosa
ECG changes in anorexia nervosaECG changes in anorexia nervosa
ECG changes in anorexia nervosa
Simon Daley
 

Similar to HISTORICAL ASPECTS OF HYPERTENSION (20)

Abc books cardiologia abc of-heart_failure
Abc books cardiologia   abc of-heart_failureAbc books cardiologia   abc of-heart_failure
Abc books cardiologia abc of-heart_failure
 
Learning Objectives1. Describe why hypertension and diabet.docx
Learning Objectives1. Describe why hypertension and diabet.docxLearning Objectives1. Describe why hypertension and diabet.docx
Learning Objectives1. Describe why hypertension and diabet.docx
 
Treating angina
Treating anginaTreating angina
Treating angina
 
Historical developments; Trends n issues; Legal n ethical issues in d field o...
Historical developments; Trends n issues; Legal n ethical issues in d field o...Historical developments; Trends n issues; Legal n ethical issues in d field o...
Historical developments; Trends n issues; Legal n ethical issues in d field o...
 
Prof. J.P.Das Oration HEART FAILURE
Prof. J.P.Das Oration HEART FAILUREProf. J.P.Das Oration HEART FAILURE
Prof. J.P.Das Oration HEART FAILURE
 
Bloodless Medicine Caring Effectively For Patients Who Decline Blood Transf...
Bloodless Medicine   Caring Effectively For Patients Who Decline Blood Transf...Bloodless Medicine   Caring Effectively For Patients Who Decline Blood Transf...
Bloodless Medicine Caring Effectively For Patients Who Decline Blood Transf...
 
History of cardiology
History of cardiologyHistory of cardiology
History of cardiology
 
avanços diabetologia.pdf
avanços diabetologia.pdfavanços diabetologia.pdf
avanços diabetologia.pdf
 
Beta blockers
Beta blockersBeta blockers
Beta blockers
 
The history of paediatric cardiology
The history of paediatric cardiologyThe history of paediatric cardiology
The history of paediatric cardiology
 
Treatment of myocardial infarction,past& present
Treatment of myocardial infarction,past& presentTreatment of myocardial infarction,past& present
Treatment of myocardial infarction,past& present
 
CHRONOPHARMACOLOGY
CHRONOPHARMACOLOGYCHRONOPHARMACOLOGY
CHRONOPHARMACOLOGY
 
Heart disease reversal
Heart disease reversal Heart disease reversal
Heart disease reversal
 
History of blood transfusion.pptx
History of blood transfusion.pptxHistory of blood transfusion.pptx
History of blood transfusion.pptx
 
Valvular Heart Disease A Century Of Progress
Valvular Heart Disease A Century Of ProgressValvular Heart Disease A Century Of Progress
Valvular Heart Disease A Century Of Progress
 
HISTORY OF PARATHYROID SURGERY 2021.ppt
HISTORY OF PARATHYROID SURGERY 2021.pptHISTORY OF PARATHYROID SURGERY 2021.ppt
HISTORY OF PARATHYROID SURGERY 2021.ppt
 
Blood pressure and cholesterol
Blood pressure and cholesterolBlood pressure and cholesterol
Blood pressure and cholesterol
 
Anesthesiology
AnesthesiologyAnesthesiology
Anesthesiology
 
Soap analysis on Coronary Artery Disease: By RxVichuZ!
Soap analysis on Coronary Artery Disease: By RxVichuZ!Soap analysis on Coronary Artery Disease: By RxVichuZ!
Soap analysis on Coronary Artery Disease: By RxVichuZ!
 
ECG changes in anorexia nervosa
ECG changes in anorexia nervosaECG changes in anorexia nervosa
ECG changes in anorexia nervosa
 

More from Praveen Nagula

BIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptxBIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptx
Praveen Nagula
 
historical aspects of hypertension.pptx
historical aspects of hypertension.pptxhistorical aspects of hypertension.pptx
historical aspects of hypertension.pptx
Praveen Nagula
 
Management of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxManagement of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptx
Praveen Nagula
 
ECGs in clinical practice.pptx
ECGs in clinical practice.pptxECGs in clinical practice.pptx
ECGs in clinical practice.pptx
Praveen Nagula
 
PCP IN STEMI.pptx
PCP IN STEMI.pptxPCP IN STEMI.pptx
PCP IN STEMI.pptx
Praveen Nagula
 
ATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptx
Praveen Nagula
 
8.FEMI.pptx
8.FEMI.pptx8.FEMI.pptx
8.FEMI.pptx
Praveen Nagula
 
RHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxRHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptx
Praveen Nagula
 
WAVES OF ECG.pptx
WAVES OF ECG.pptxWAVES OF ECG.pptx
WAVES OF ECG.pptx
Praveen Nagula
 
BASICS OF ECG.pptx
BASICS OF ECG.pptxBASICS OF ECG.pptx
BASICS OF ECG.pptx
Praveen Nagula
 
HISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxHISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptx
Praveen Nagula
 
QUIZ IV
QUIZ IVQUIZ IV
QUIZ .pptx
QUIZ .pptxQUIZ .pptx
QUIZ .pptx
Praveen Nagula
 
QUIZ
QUIZ QUIZ
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes management
Praveen Nagula
 
Beta blockers all are not same
Beta blockers   all are not sameBeta blockers   all are not same
Beta blockers all are not same
Praveen Nagula
 
INTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIINTERESTING ECGS -- PART II
INTERESTING ECGS -- PART II
Praveen Nagula
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL
Praveen Nagula
 
HF update 2021
HF update 2021HF update 2021
HF update 2021
Praveen Nagula
 
Heart Failure - What to expect from the Investigations?
Heart Failure - What to expect from the Investigations?Heart Failure - What to expect from the Investigations?
Heart Failure - What to expect from the Investigations?
Praveen Nagula
 

More from Praveen Nagula (20)

BIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptxBIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptx
 
historical aspects of hypertension.pptx
historical aspects of hypertension.pptxhistorical aspects of hypertension.pptx
historical aspects of hypertension.pptx
 
Management of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxManagement of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptx
 
ECGs in clinical practice.pptx
ECGs in clinical practice.pptxECGs in clinical practice.pptx
ECGs in clinical practice.pptx
 
PCP IN STEMI.pptx
PCP IN STEMI.pptxPCP IN STEMI.pptx
PCP IN STEMI.pptx
 
ATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptx
 
8.FEMI.pptx
8.FEMI.pptx8.FEMI.pptx
8.FEMI.pptx
 
RHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxRHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptx
 
WAVES OF ECG.pptx
WAVES OF ECG.pptxWAVES OF ECG.pptx
WAVES OF ECG.pptx
 
BASICS OF ECG.pptx
BASICS OF ECG.pptxBASICS OF ECG.pptx
BASICS OF ECG.pptx
 
HISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxHISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptx
 
QUIZ IV
QUIZ IVQUIZ IV
QUIZ IV
 
QUIZ .pptx
QUIZ .pptxQUIZ .pptx
QUIZ .pptx
 
QUIZ
QUIZ QUIZ
QUIZ
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes management
 
Beta blockers all are not same
Beta blockers   all are not sameBeta blockers   all are not same
Beta blockers all are not same
 
INTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIINTERESTING ECGS -- PART II
INTERESTING ECGS -- PART II
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL
 
HF update 2021
HF update 2021HF update 2021
HF update 2021
 
Heart Failure - What to expect from the Investigations?
Heart Failure - What to expect from the Investigations?Heart Failure - What to expect from the Investigations?
Heart Failure - What to expect from the Investigations?
 

Recently uploaded

1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 

Recently uploaded (20)

1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 

HISTORICAL ASPECTS OF HYPERTENSION

  • 1. Historical Milestones in Hypertension and its Management Dr. Nagula Praveen MD,DM Associate Professor of Cardiology Osmania General Hospital Hyderabad
  • 2. Study the past, if you would define the future. - Confucius
  • 3. WILLIAM HARVEY English Physician Circulation of the Heart and Blood 1628 STEPHEN HALES English Clergyman First person to measure blood pressure 1733 RIVA ROCCI Italian Mercury sphygmomanometer 1896 N.C. KOROTKOFF Russian 1905 reported on the method of auscultation of brachial artery, the method which is widely used today.
  • 4. The term essential hypertension ('Essentielle Hypertonie') was coined by Eberhard Frank in 1911 to describe elevated blood pressure for which no cause could be found. Thomas Young - Hypertension as a disease 1808 Malignant hypertension, a term used to describe severe hypertension which eventually resulted in death, was first used by The Mayo Clinic in 1928.
  • 5. “Hypertension may be an important compensatory mechanism which should not be tampered with, even were it certain that we could control it”. –Paul Dudley White, Father of Preventive Cardiology.
  • 6. FRANKLIN D. ROOSEVELT The 32nd President of the United States
  • 7. President Franklin D. Roosevelt was given a clean bill of health by his physician even when his BP was recorded as ~220/120. A few years later while at Yalta, Winston Churchill’s personal physician noted in his diary that President Roosevelt “appeared to be have had signs of ‘hardening of the arteries disease’ and had a few months to live.” President Roosevelt ultimately had a fatal hemorrhagic stroke 2 months later, and his death brought hypertension’s potential as a deadly to the limelight. Three years after Roosevelt’s death, the pivotal National Heart Act was signed into law by President Truman. The Act created the path for the study of heart diseases and resulted in several studies including the Framingham Heart Study.
  • 9. Schematic model of the evolution of understanding and approaches to hypertension in the 20th century.
  • 11.
  • 12.
  • 13. Miguel Ondetti and David Cushman, 1975 developed Captopril, the first of a new class of drugs known as angiotensin converting enzyme (ACE) inhibitors. James Whyte Black, 1962 Developed propranolol, a beta blocker used for the treatment of heart disease
  • 14. I wish I had my betablockers handy -Dr. James Black, 1988
  • 15.
  • 16. Evolution of Blood Pressure Clinical Practice Guidelines
  • 17.
  • 18.
  • 19. Conclusion: This study showed the clinical efficacy, safety and acceptability of the perindopril/indapamide/amlodipine SPC in patients with grade 2/3 hypertension inadequately controlled with two drug therapy. The clinical effectiveness was observed in more than 96% patients. The benefit of SPC therapy in hypertension control was reconfirmed in this study.
  • 20. Hypertension Screening on Occasion of World Hypertension Day 2022 • Of the approximately 4500 patients screened, around 800+ patients were screened at OGH, Hyderabad. 3565 922 Males Females
  • 22. 22 0 500 1000 1500 2000 2500 3000 3500 4000 4500 5000 BMI ≥24.0 kg/m2 (Over weight/Obesity) > = 24.0(over weight/Obesity) 70.8 %